Ming capital

Total investments

7

Average round size

18M

Portfolio companies

6

Follow on index

0.14

Areas of investment
BiotechnologySoftwareArtificial IntelligenceHealth CareHealth DiagnosticsMedical DeviceMedicalPersonal HealthOptical CommunicationHuman Computer Interaction

Summary

The company was established in Asia in China. The main office of represented VC is situated in the Shenzhen.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Apps, Human Computer Interaction. Among the most popular portfolio startups of the fund, we may highlight Miracor Medical, 0glass. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Ming capital, startups are often financed by SHS Gesellschaft fur Beteiligungsmanagement, Earlybird Venture Capital, Delta Partners. The meaningful sponsors for the fund in investment in the same round are SFPI-FPIM, Meusinvest, SHS Gesellschaft fur Beteiligungsmanagement. In the next rounds fund is usually obtained by Yungpark Lingzhong Fund, SFPI-FPIM, Quest for Growth.

The real fund results show that this VC is 47 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year.

Show more

Investments analytics

Analytics

Total investments
7
Lead investments
0
Follow on index
0.14
Investments by industry
  • Medical Device (4)
  • Health Care (4)
  • Medical (3)
  • Health Diagnostics (3)
  • Personal Health (2)
  • Show 7 more
Investments by region
  • China (4)
  • Belgium (2)
  • United States (1)
Peak activity year
2018

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
54M
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Svision 09 Mar 2023 Health Care, Health Diagnostics, Medical Device Late Stage Venture 46M Guangdong Province, Huizhou, China
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.